Genetic testing and precision medicine enhance early detection and personalized treatment, potentially reducing morbidity and mortality. We examined how beliefs and perceptions of genetic testing and precision medicine differ by cancer history, gender, rural-urban status, physical activity, and obesity. We analyzed 3865 respondents from the Health Information National Trends Survey (HINTS) 5, Cycle 4, administered February 2020–June 2020. We assessed the associations between cancer history, demographic and health-related factors, with knowledge, beliefs, and perceptions of genetic testing and precision medicine. Adjusted Odds Ratios (AORs) and 95 % Confidence Intervals (CIs) were calculated. Cancer survivors were more likely to have had genetic testing (AOR = 1.61; 95 % CI, 1.03–2.53) and to want to know if a genetic change increases cancer risk (AOR = 1.65; 95 % CI, 1.12–2.44). Men were more likely to report knowledge of precision medicine (AOR = 1.52; 95 % CI, 1.16–1.98) but less likely to believe genetic information is important for cancer prevention (AOR = 0.72; 95 % CI, 0.55–0.94). Those with less physical activity were less likely to report knowledge of precision medicine (AOR = 0.67; 95 % CI, 0.47–0.96) and genetic tests (AOR = 0.70; 95 % CI, 0.51–0.97). Individuals with obesity were more likely to believe genetic information is important for preventing (AOR = 1.36; 95 % CI, 1.06–1.75) and treating cancer (AOR = 1.27; 95 % CI, 1.02–1.59). Knowledge and beliefs about genetic testing and precision medicine vary by sociodemographic factors, in particular individuals with obesity are more likely to value genetic information.
Cervical cancer remains the leading cause of cancer-related mortality among women in Nepal, where national screening coverage is approximately 16%. This study evaluated the feasibility of a community-based, door-to-door self-sampling strategy for high-risk human papillomavirus (hrHPV) detection in an urban municipality of central Nepal and assessed hrHPV prevalence, genotype distribution, screening outcomes, and associated demographic factors. A cross-sectional study was conducted between September 2023 and May 2024 in Ward No. 3 of Lalitpur Metropolitan City. Women aged 30–60 years were recruited through trained community health workers, provided education and home-based self-sampling kits, and completed a demographic questionnaire. Dry cervical swabs from 418 participants were tested for hrHPV. Women with positive results underwent visual inspection with acetic acid (VIA), followed by colposcopy, biopsy when indicated, and thermal ablation for confirmed precancerous lesions. Overall participation was 64.1%, and hrHPV prevalence was 10.3%. Non-16/18 hrHPV genotypes predominated (55.8%), followed by HPV16 (20.9%). Women aged > 50 years were more likely to be hrHPV- and VIA-positive (OR = 7.39, p = 0.02). Six pre-cancer cases were identified: five cervical intraepithelial neoplasia (CIN1) and one CIN3 case. Community-based hrHPV self-sampling was found to be feasible and achieved effective linkage to triage and treatment, supporting its consideration for strengthening cervical cancer screening in Nepal.
Purpose: Early-onset colorectal cancer (EOCRC, < 50 years) is rising in the United States, whereas late-onset CRC (LOCRC, ≥ 50 years) is declining. Fewer studies have examined association between risk factors and age at colorectal (CRC) diagnosis by race. Hence, we investigated whether associations between lifestyle and clinical risk factors and age at CRC diagnosis differed by race. Methods: Retrospective study conducted between 2010 and 2023 using data from a tertiary medical center in Alabama. Exposure included lifestyle factors—smoking status, and body mass index; clinical factors—type 2 diabetes (T2D), hypertension, and hyperlipidemia. Outcome was age at CRC diagnosis categorized as LOCRC and EOCRC. Multivariable logistic regression was used to examine association between lifestyle and clinical risk factors with age at CRC diagnosis after controlling for race, sex, and marital status. Race-stratified analyses were conducted. Results: Among 3,209 CRC patients, 54.1% were male, 71.4% White, and 55.8% were married. LOCRC was diagnosed in 81.2%. Patients who were former smokers (OR: 1.89; 95% CI: 1.50, 2.39), had T2D (OR: 1.92; 95% CI: 1.44, 2.57), hypertension (OR: 2.46; 95% CI: 1.65, 3.66), and hyperlipidemia (OR: 3.32; 95% CI: 2.35, 4.70) had higher odds of LOCRC, whereas obesity (OR: 0.61; 95% CI: 0.48, 0.77) had lower odds of LOCRC compared to EOCRC. Hypertension showed significant association with LOCRC in White patients. Hyperlipidemia showed stronger association with LOCRC in Black patients. Conclusion: Obesity was more prevalent in EOCRC patients and hence these differences should be considered in development of age-stratified screening and prevention strategies.